Your browser doesn't support javascript.
loading
Entecavir plus Biejia-Ruangan compound reduces the risk of hepatocellular carcinoma in Chinese patients with chronic hepatitis B.
Ji, Dong; Chen, Yan; Bi, Jingfeng; Shang, Qinghua; Liu, Huabao; Wang, Jia-Bo; Tan, Lin; Wang, Jing; Chen, Yongping; Li, Qin; Long, Qinghua; Song, Laicheng; Jiang, Li; Xiao, Guangming; Yu, Zujiang; Chen, Liang; Wang, Xiaodong; Chen, Da; Li, Zhiqin; Dong, Zheng; Yang, Yongping.
Afiliação
  • Ji D; Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Chen Y; Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Bi J; Senior Department of Infectious Diseases, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Shang Q; Diagnosis and Treatment Center for Liver Diseases, The 960th Hospital of Chinese PLA Joint Logistics Support Force, Tai'an, Shandong, China.
  • Liu H; Chongqing Traditional Chinese Medicine Hospital, Chongqing, China.
  • Wang JB; Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China; School of Traditional Chinese Medicine, Capital Medical University, Beijing, China.
  • Tan L; Liver Disease Department, The Second People's Hospital of Fuyang City, Fuyang, Anhui, China.
  • Wang J; Affiliated Traditional Chinese Medicine Hospital of Southwest Medical University, Luzhou, Sichuan, China.
  • Chen Y; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Li Q; Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Long Q; Department of Infection and Liver Disease, Yichun People's Hospital, Yichun, Jiangxi, China.
  • Song L; Traditional Chinese Medicine Hospital of Taihe, Taihe, Anhui, China.
  • Jiang L; Department of Infectious Diseases, Southwest Hospital, Army Medical University (Third Military Medical University), Chongqing, China.
  • Xiao G; Guangzhou Eighth People's Hospital, Guangzhou Medical University, Guangzhou, China.
  • Yu Z; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Chen L; Department of Hepatic Diseases, Shanghai Public Health Clinical Center, Shanghai, China.
  • Wang X; Department of Infectious Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
  • Chen D; Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, Fujian, China.
  • Li Z; Department of Infectious Disease, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Dong Z; Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
  • Yang Y; Senior Department of Hepatology, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. Electronic address: yongpingyang@hotmail.com.
J Hepatol ; 77(6): 1515-1524, 2022 12.
Article em En | MEDLINE | ID: mdl-35985545

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Hepatite B Crônica / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Risk_factors_studies Limite: Adult / Female / Humans / Male País/Região como assunto: Asia Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China